CODX - コ・ダイアグノスティックス （Co-Diagnostics Inc.）

Class action lawsuit charges Co-Diagnostics and certain of its top executive officers with violations of the Securities Exchange Act of 1934.

Co-Diagnostics faces a federal lawsuit for allegedly making false, misleading statements to inflate its stock price to benefit directors.

We reiterate the hold thesis on Co-Diagnostics following Q2 FY22 earnings as Covid-19 turnover continues to diminish. Read our analysis of CODX here.

SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Co-Diagnostics, Inc. (NASDAQ: CODX) investors who suffered significant losses to submit your losses now .

The shares of Co-Diagnostics (CODX) are trading higher for the third straight session on Friday in solidarity with makers of monkeypox vaccines and therapeutics after molecular…

The company is not monkeying around with the latest possible global health menace.

SALT LAKE CITY, May 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the principal design…

Co-Diagnostics, Inc. (NASDAQ:NASDAQ:CODX) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants Andrew Benson - Head, IR Dwight Egan - Chairman, CEO & President…

Co-Diagnostics Inc (NASDAQ: CODX ) reported first-quarter revenue growth of 13.4% year-over-year to $22.7 million , beating the consensus of $20.17 million. Co-Diagnostics Inc (NASDAQ: CODX ) reported first-quarter revenue growth of 13.4% year-over-year to $22.7 million , beating the consensus of $20.17 million. The increase in revenue is attributable to the Logix Smart™ COVID-19 Test sales. EPS was $0.34 for the quarter, above the consensus of $0.17. The gross margin expanded by 188 bps to 85.5%. Operating … Full story available on Benzinga.com

Co-Diagnostics Inc (CODX) shares closed this week 38.3% higher than it did at the end of last week. The stock is currently up 13.3% year-to-date, down 50.4% over the past 12 months, and up 81.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 rose 0.2%. Trading Activity Shares traded as high as $11.20 and as low as $7.69 this week.Shares closed 70.6% below its 52-week high and 30.1% above its 52-week low.Trading volume this week was 341.6% higher than the 10-day average and 778.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 1.2% higher than its 5-day moving average, 8.6% higher than its 20-day moving average, and 2.2% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -67.8% The company's stock price performance over the past 12 months lags the peer average by -218.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.7% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

New York , June 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: